BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26439773)

  • 1. Retracted: A new contemporary prostate cancer grading system.
    Epstein JI
    Pathol Int; 2015 Oct; ():. PubMed ID: 26439773
    [No Abstract]   [Full Text] [Related]  

  • 2. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
    Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
    Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.
    Kryvenko ON; Epstein JI
    Arch Pathol Lab Med; 2016 Oct; 140(10):1140-52. PubMed ID: 26756649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on the Gleason grading of prostate cancer.
    Shah RB
    Arch Pathol Lab Med; 2009 Nov; 133(11):1810-6. PubMed ID: 19886716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
    Epstein JI; Zelefsky MJ; Sjoberg DD; Nelson JB; Egevad L; Magi-Galluzzi C; Vickers AJ; Parwani AV; Reuter VE; Fine SW; Eastham JA; Wiklund P; Han M; Reddy CA; Ciezki JP; Nyberg T; Klein EA
    Eur Urol; 2016 Mar; 69(3):428-35. PubMed ID: 26166626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary grading for prostate cancer: implications for patient care.
    Brimo F; Montironi R; Egevad L; Erbersdobler A; Lin DW; Nelson JB; Rubin MA; van der Kwast T; Amin M; Epstein JI
    Eur Urol; 2013 May; 63(5):892-901. PubMed ID: 23092544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
    Egevad L; Delahunt B; Srigley JR; Samaratunga H
    APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in prostate cancer pathology: Gleason grading and beyond.
    Shah RB; Zhou M
    Pathol Int; 2016 May; 66(5):260-72. PubMed ID: 26991008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians.
    Gasparrini S; Cimadamore A; Scarpelli M; Massari F; Doria A; Mazzucchelli R; Cheng L; Lopez-Beltran A; Montironi R
    Asian J Androl; 2017 Aug; 21(1):19-23. PubMed ID: 28782737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading of Prostate Cancer: Past, Present, and Future.
    Matoso A; Epstein JI
    Curr Urol Rep; 2016 Mar; 17(3):25. PubMed ID: 26874537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current practice of Gleason grading of prostate carcinoma.
    Lopez-Beltran A; Mikuz G; Luque RJ; Mazzucchelli R; Montironi R
    Virchows Arch; 2006 Feb; 448(2):111-8. PubMed ID: 16328356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new contemporary prostate cancer grading system: message to the Italian pathologists.
    Epstein JI
    Pathologica; 2015; 107(3-4):205-7. PubMed ID: 26946878
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review.
    Kamitani R; Matsumoto K; Kosaka T; Takeda T; Hashiguchi A; Tanaka N; Morita S; Mizuno R; Shinojima T; Asanuma H; Oya M
    Clin Genitourin Cancer; 2021 Feb; 19(1):69-75.e5. PubMed ID: 32863190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on 'Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome'.
    Dell'Oglio P; Stabile A; Gandaglia G; Briganti A
    Br J Cancer; 2017 Jan; 116(3):e3. PubMed ID: 27780195
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to 'Comment on "Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome"'.
    Berney DM
    Br J Cancer; 2017 Jan; 116(3):e4. PubMed ID: 27780194
    [No Abstract]   [Full Text] [Related]  

  • 16. A new contemporary prostate cancer grading system.
    Epstein JI
    Ann Pathol; 2015 Dec; 35(6):474-6. PubMed ID: 26586013
    [No Abstract]   [Full Text] [Related]  

  • 17. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in prostate cancer grading: Including a new patient-centric grading system.
    Kryvenko ON; Epstein JI
    Prostate; 2016 Apr; 76(5):427-33. PubMed ID: 26709152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
    Grossfeld GD; Chang JJ; Broering JM; Li YP; Lubeck DP; Flanders SC; Carroll PR
    J Urol; 2001 Mar; 165(3):851-6. PubMed ID: 11176485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer.
    Sopyllo K; Erickson AM; Mirtti T
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.